GSE207376 GSE207377 nutlin-3 0 v 5 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE207376_GSE207377_nutlin-3_0_v_5_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE207376_GSE207377_nutlin-3_0_v_5_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE207376_GSE207377_nutlin-3_0_v_5_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE207376_GSE207377_nutlin-3_0_v_5_human_up.

Results found

Linked to

 

Label

Description

 

Gene

SOCS2 antisense RNA 1

Gene

SACK1A antisense RNA 1

Gene

long intergenic non-protein coding RNA 705

Gene

platelet derived growth factor receptor like 2, pseudogene

Gene

uncharacterized LOC105375478

Gene

ribonuclease MRP subunit p24 pseudogene

Gene

RNA, 7SL, cytoplasmic 123, pseudogene

Gene

RNA, U5F small nuclear 1

Gene

microRNA 5194

Gene

CDYL antisense RNA 1

  • Gene

    SOCS2 antisense RNA 1


  • Gene

    SACK1A antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 705


  • Gene

    platelet derived growth factor receptor like 2, pseudogene


  • Gene

    uncharacterized LOC105375478


  • Gene

    ribonuclease MRP subunit p24 pseudogene


  • Gene

    RNA, 7SL, cytoplasmic 123, pseudogene


  • Gene

    RNA, U5F small nuclear 1



  • Gene

    CDYL antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.